Having trouble accessing articles? Reset your cache.

Avastin bevacizumab: Postmarketing study data

There were no significant differences in the risk of myocardial infarction (MI) or ischemic cerebrovascular accident between treatment groups. The authors of the study said the data suggest differences in the safety profiles

Read the full 339 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE